220 related articles for article (PubMed ID: 24970479)
1. Chromosomal instability selects gene copy-number variants encoding core regulators of proliferation in ER+ breast cancer.
Endesfelder D; Burrell R; Kanu N; McGranahan N; Howell M; Parker PJ; Downward J; Swanton C; Kschischo M
Cancer Res; 2014 Sep; 74(17):4853-4863. PubMed ID: 24970479
[TBL] [Abstract][Full Text] [Related]
2. Paradoxical relationship between chromosomal instability and survival outcome in cancer.
Birkbak NJ; Eklund AC; Li Q; McClelland SE; Endesfelder D; Tan P; Tan IB; Richardson AL; Szallasi Z; Swanton C
Cancer Res; 2011 May; 71(10):3447-52. PubMed ID: 21270108
[TBL] [Abstract][Full Text] [Related]
3. Relationship of extreme chromosomal instability with long-term survival in a retrospective analysis of primary breast cancer.
Roylance R; Endesfelder D; Gorman P; Burrell RA; Sander J; Tomlinson I; Hanby AM; Speirs V; Richardson AL; Birkbak NJ; Eklund AC; Downward J; Kschischo M; Szallasi Z; Swanton C
Cancer Epidemiol Biomarkers Prev; 2011 Oct; 20(10):2183-94. PubMed ID: 21784954
[TBL] [Abstract][Full Text] [Related]
4. High nuclear TPX2 expression correlates with TP53 mutation and poor clinical behavior in a large breast cancer cohort, but is not an independent predictor of chromosomal instability.
Matson DR; Denu RA; Zasadil LM; Burkard ME; Weaver BA; Flynn C; Stukenberg PT
BMC Cancer; 2021 Feb; 21(1):186. PubMed ID: 33622270
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide chromosomal instability by cell-free DNA sequencing predicts survival in patients with metastatic breast cancer.
Mo H; Wang X; Ma F; Qian Z; Sun X; Yi Z; Guan X; Li L; Liu B; Xu B
Breast; 2020 Oct; 53():111-118. PubMed ID: 32738630
[TBL] [Abstract][Full Text] [Related]
6. Centromere 17 copy number gain reflects chromosomal instability in breast cancer.
Lee K; Kim HJ; Jang MH; Lee S; Ahn S; Park SY
Sci Rep; 2019 Nov; 9(1):17968. PubMed ID: 31784614
[TBL] [Abstract][Full Text] [Related]
7. TPX2 overexpression promotes sensitivity to dasatinib in breast cancer by activating YAP transcriptional signaling.
Marugán C; Sanz-Gómez N; Ortigosa B; Monfort-Vengut A; Bertinetti C; Teijo A; González M; Alonso de la Vega A; Lallena MJ; Moreno-Bueno G; de Cárcer G
Mol Oncol; 2024 Jun; 18(6):1531-1551. PubMed ID: 38357786
[TBL] [Abstract][Full Text] [Related]
8. Patterns and incidence of chromosomal instability and their prognostic relevance in breast cancer subtypes.
Smid M; Hoes M; Sieuwerts AM; Sleijfer S; Zhang Y; Wang Y; Foekens JA; Martens JW
Breast Cancer Res Treat; 2011 Jul; 128(1):23-30. PubMed ID: 20632083
[TBL] [Abstract][Full Text] [Related]
9. Twist1 induces chromosomal instability (CIN) in colorectal cancer cells.
Khot M; Sreekumar D; Jahagirdar S; Kulkarni A; Hari K; Faseela EE; Sabarinathan R; Jolly MK; Sengupta K
Hum Mol Genet; 2020 Jun; 29(10):1673-1688. PubMed ID: 32337580
[TBL] [Abstract][Full Text] [Related]
10. Extreme chromosomal instability forecasts improved outcome in ER-negative breast cancer: a prospective validation cohort study from the TACT trial.
Jamal-Hanjani M; A'Hern R; Birkbak NJ; Gorman P; Grönroos E; Ngang S; Nicola P; Rahman L; Thanopoulou E; Kelly G; Ellis P; Barrett-Lee P; Johnston SR; Bliss J; Roylance R; Swanton C
Ann Oncol; 2015 Jul; 26(7):1340-6. PubMed ID: 26003169
[TBL] [Abstract][Full Text] [Related]
11. Single-cell RNA sequencing reveals the impact of chromosomal instability on glioblastoma cancer stem cells.
Zhao Y; Carter R; Natarajan S; Varn FS; Compton DA; Gawad C; Cheng C; Godek KM
BMC Med Genomics; 2019 May; 12(1):79. PubMed ID: 31151460
[TBL] [Abstract][Full Text] [Related]
12. Determinants and clinical implications of chromosomal instability in cancer.
Sansregret L; Vanhaesebroeck B; Swanton C
Nat Rev Clin Oncol; 2018 Mar; 15(3):139-150. PubMed ID: 29297505
[TBL] [Abstract][Full Text] [Related]
13. The AURKA/TPX2 axis drives colon tumorigenesis cooperatively with MYC.
Takahashi Y; Sheridan P; Niida A; Sawada G; Uchi R; Mizuno H; Kurashige J; Sugimachi K; Sasaki S; Shimada Y; Hase K; Kusunoki M; Kudo S; Watanabe M; Yamada K; Sugihara K; Yamamoto H; Suzuki A; Doki Y; Miyano S; Mori M; Mimori K
Ann Oncol; 2015 May; 26(5):935-942. PubMed ID: 25632068
[TBL] [Abstract][Full Text] [Related]
14. Chromosomal instability in untreated primary prostate cancer as an indicator of metastatic potential.
Miller ET; You S; Cadaneanu RM; Kim M; Yoon J; Liu ST; Li X; Kwan L; Hodge J; Quist MJ; Grasso CS; Lewis MS; Knudsen BS; Freeman MR; Garraway IP
BMC Cancer; 2020 May; 20(1):398. PubMed ID: 32380981
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide single-nucleotide polymorphism arrays in endometrial carcinomas associate extensive chromosomal instability with poor prognosis and unveil frequent chromosomal imbalances involved in the PI3-kinase pathway.
Murayama-Hosokawa S; Oda K; Nakagawa S; Ishikawa S; Yamamoto S; Shoji K; Ikeda Y; Uehara Y; Fukayama M; McCormick F; Yano T; Taketani Y; Aburatani H
Oncogene; 2010 Apr; 29(13):1897-908. PubMed ID: 20062086
[TBL] [Abstract][Full Text] [Related]
16. Integrative molecular profiling identifies a novel cluster of estrogen receptor-positive breast cancer in very young women.
Park C; Yoon KA; Kim J; Park IH; Park SJ; Kim MK; Jang W; Cho SY; Park B; Kong SY; Lee ES
Cancer Sci; 2019 May; 110(5):1760-1770. PubMed ID: 30811755
[TBL] [Abstract][Full Text] [Related]
17. Expression of regulators of mitotic fidelity are associated with intercellular heterogeneity and chromosomal instability in primary breast cancer.
Roylance R; Endesfelder D; Jamal-Hanjani M; Burrell RA; Gorman P; Sander J; Murphy N; Birkbak NJ; Hanby AM; Speirs V; Johnston SR; Kschischo M; Swanton C
Breast Cancer Res Treat; 2014 Nov; 148(1):221-9. PubMed ID: 25288231
[TBL] [Abstract][Full Text] [Related]
18. EPRS is a critical regulator of cell proliferation and estrogen signaling in ER+ breast cancer.
Katsyv I; Wang M; Song WM; Zhou X; Zhao Y; Park S; Zhu J; Zhang B; Irie HY
Oncotarget; 2016 Oct; 7(43):69592-69605. PubMed ID: 27612429
[TBL] [Abstract][Full Text] [Related]
19. Centrosome Aberrations as Drivers of Chromosomal Instability in Breast Cancer.
Piemonte KM; Anstine LJ; Keri RA
Endocrinology; 2021 Dec; 162(12):. PubMed ID: 34606589
[TBL] [Abstract][Full Text] [Related]
20. PRMT2 and RORγ expression are associated with breast cancer survival outcomes.
Oh TG; Bailey P; Dray E; Smith AG; Goode J; Eriksson N; Funder JW; Fuller PJ; Simpson ER; Tilley WD; Leedman PJ; Clarke CL; Grimmond S; Dowhan DH; Muscat GE
Mol Endocrinol; 2014 Jul; 28(7):1166-85. PubMed ID: 24911119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]